IGXBio
Biotechnology company developing advanced dna immunotherapies for hiv infection.
Launch date
Employees
Market cap
-
Enterprise valuation
€2—3m (Dealroom.co estimates Dec 2010.)
Lenexa Kansas (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$470k | Seed | ||
Total Funding | €427k |
Recent News about IGXBio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.